DouglasAArenbergMD

PubMed

• 41 citations
  Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.
  Christine M. Freeman, Valerie R. Stolberg, Sean Crudgington, Fernando J. Martinez, MeiLan K. Han
  Plos One. 2014-07-31
• 326 citations
  Treatment of Stage III Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practi...
  Nithya Ramnath, Thomas J. Dilling, Loren J. Harris, Anthony W. Kim, Gaetane Michaud
  Chest. 2013-05-01
• 148 citations
  The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the For...
  Frank C. Detterbeck, Andrew G. Nicholson, Wilbur A. Franklin, Edith M. Marom, William D. Travis
  Journal of Thoracic Oncology. 2016-05-01

Journal Articles

• Nodule Volume Measurement: pushing the Pendulum  
  Arenberg, DA, Chest, 3/1/2014
• Implementation of a Lung Cancer-Screening Program  
  Arenberg DA, Current Surgery Reports, 1/1/2013
• IASLC CT Screening Workshop 2011: Expert Pulmonary Group International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report  
  Field JK , et al, J Thorac Oncol, 1/1/2012
• Changes in Global Function and Regional Ventilation and Perfusion on SPECT During the Course of Radiotherapy in Patients with Non-small Lung Cancer  
  Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg DA, Cai XW, Ramnath N, Hassan K, Moran J, Eisbruch A, Ten Haken RK, Kong FM, Int J Radiat Onco Biol Phys, 1/1/2012
• Semiquantification and Classification of Local Pulmonary Function by V/Q Single Photon Emission Computed Tomography in Patients with Non-small Cell Lung Cance: Potenti...  
  Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg DA, Curtis JL, Cai XW, Ramnath N, Kalemkerian GP, Ten Haken RK, Eisbruch A, Kong FM, J Thorac Onco, 1/1/2011
• Invited Editorial PET scans for spolitary pulmonary nodules: Costs and cost effectivelness  
  Arenberg, DA, Chest, 1/1/2010
• Time to Treatment in Patients with Stage III Non-small Cell Lung Cancer  
  Wang L, Correa CR, Hayman JA, Zhao L, Cease K, Brenner D, Arenberg D, Curtis J, Kalemkerian GP, Kong FM, Int J Radiat Oncol Biol Phys, 7/1/2009
• Expression of CD74, the Receptor for Macrophage Migration Inhibitory Factor (MIF), in Non-Small Cell Lung Cancer  
  McClelland MR, Zhao L, Carskadon SL, Arenberg DA, Am J Pathol, 1/1/2009
• Chemokines in the biology of lung cancer  
  Arenberg DA, J Thoracic Onc, 1/1/2006
• Peroxisome proliferator activated receptor-gamma activation inhibits tumor progression in non-small cell lung cancer  
  Keshamouni VG, Reddy RC, Arenberg DA, Joel B, Thannickal VJ, Kalemkerian GP, Standiford TJ, Oncogene, 1/1/2004
• Chemokines as therapeutic targets in non-small cell lung cancer  
  Arenberg D, Med Chem Rev Online, 1/1/2004
• Lung cancer: selecting patients for surgery  
  Arenberg D, J Resp Dis, 1/1/2004
• Evaluating the patient with suspected lung cancer  
  Arenberg D, J Resp Dis, 1/1/2004
• Invited Editorial In search of the Holy Grail: Lung Cancer Biomarkers  
  Arenberg, DA, Chest, 1/1/2004
• Macrophage migration inhibitory factor (MIF) and CXC chemokine expression in human non-small cell lung cancer (NSCLC): role in angiogenesis and prognosis  
  White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg, DA, Clin Can Res, 1/1/2003
•  
  White ES, Carskadon SL, Dickey EG, Livant DL, Markwart S, Arenberg DA, Am J Resp Crit Care Med, 1/1/2003
• Chemokines as therapeutic targets in non-small cell lung cancer  
  White EW, Strieter RM, Arenberg DA, Curr Med Chem Anticancer Agents, 1/1/2002
• RANTES expression by lung adenocarcinoma is a predictor of survival in stage I patients  
  Moran CJ, Arenberg DA, Huang C, Giordano TJ, Thomas DG, Misek DE, Hanash S, Iannettoni MD, Orringer MB, Beer DG, Clin Can Res, 1/1/2002
• Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity  
  White EW, Strom SR, Wys NB, Arenberg DA, J Immunol, 1/1/2001
• Monocyte-fibronectin interactions, via alpha5beta1 integrin, induce expression of CXC chemokine dependent angiogenic activity  
  White EW, Livant DL, Markwart S, Arenberg DA, J Immunol, 1/1/2001
• Overexpression of CXC-chemokines by an adrenocortical carcinoma: A novel clinical syndrome  
  Schteingart DE, Giordano TJ, Benitez R, Burdick M, Starkman MN, Arenberg DA, Strieter RM, J Clin Endocrinol Metab, 1/1/2001
• The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer model  
  Arenberg DA, Zlotnick A, Strom SR, Burdick MD, Strieter RM, Cancer Immunol Immunother, 1/1/2001
• Improved survival in tumor bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10)  
  Arenberg DA, White ES, Burdick MD, Strom SR, Strieter RM, Cancer Immunol Immunother, 1/1/2001
• CXC chemokines in angiogenesis  
  Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM, J Leuk Biol, 1/1/2000
• The CXC chemokine, monokine induced by interferon gamma (MIG), inhibits non-small cell lung cancer (NSCLC) tumor growth and metastasis  
  Addison C, Arenberg DA, Morris SB, Xue Y, Burdick MD, Mulligan MS, Iannetoni MD, Strieter RM, Hum Gene Ther, 1/1/2000
• Join now to see all

Books/Book Chapters

• Clinical Respiratory Medicine 
  Chapter: Lung cancer Treatment, Chapter 67 
  Arenberg, DAEditors: S. Spiro, G.A. Silvestri, and A. Agusti.Edition 4th,2012
• Novel Biological Mechanisms and Impact on Clinical Practice. 
  Chapter: Angiogenic diversity and lung cancer metastasis in Lung Cancer Metastasis 
  Arenberg, DAEditors: V. Keshamouni, D. Arenberg, and G. Kalemkerian.Springer, New York, NY2009
• Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice. 
  Editors: V. Keshamouni, D. Arenberg, G. Kalemkerian.Springer, New York, NY2009
• The Cytokine Handbook 
  Chapter: Macrophage migration inhibitory factor (MIF). Chapter 45 
  Page 1037 - 1048Arenberg DA and Bucala REditors: A. Thomson and M. Lotze.Academic Press, London, UKEdition 4th,2003
• Inflammation: Basic Principles and Clinical Correlates. 
  Chapter: Angiogenesis. 
  Page 851 - 864Arenberg DA, Strieter RMEditors: J. Gallin and R. Snyderman.Lippincott Williams & Wilkins, Philadelphia, PAEdition 3rd,1999
• Chemokines and Cancer 
  Chapter: CXC chemokines and lung cancer angiogenesis. 
  Page 3 - 19Strieter RM, DiGiovine B, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Arenberg DAEditors: Barrett J. Rollins.Humana Press, Totowa, NJ1999
• Chemokines in Disease: Biology and Clinical Research. 
  Chapter: The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. 
  Page 171 - 182Strieter RM, Addison CA, Moore BB, Arenberg DAEditors: C. Hebert.Humana Press, Totowa, NJ1999
• Molecular and Cellular Basis of Inflammation. 
  Chapter: Angiogenesis. 
  Page 29 - 49Arenberg DA, Strieter RMEditors: C. Serhan and P. Ward.Humana Press, Totowa, NJ1999
• The Role of Chemokines in Disease. 
  Chapter: The role of CXC chemokines in regulation of angiogenesis. 
  Page 195 - 210Strieter RM, Kunkel SL, Shanafelt AB, Arenberg DA, Koch AE, Polverini PJEditors: A. Koch and R. Strieter.Landes Co. Publishers, Austin, TX1996
• Murray & Nadel’s Textbook of Respiratory Medicine 
  Chapter: Metastatic Lung Tumors. Chapter 49 
  Arenberg, DA, Pickens, AEditors: Mason, R., Broaddus, V.C., King, T., Schraufnagel, D., Martin, T.R., Murray, J.F., Nadel, J..Edition 5th,
• Join now to see all

Abstracts/Posters

• Lung injury accelerates growth of lung cancer cells in an orthotopic model of lung cancer.
  Arenberg DA, Carskadon SL, Zhao L, American Thoracic Society, Toronto, Ontario, Canada, 5/1/2008
• The tumor microenvironment modulates the angiogenic phenotype in lung cancer. Diversity and plasticity of the angiogenic switch in lung cancer.
  Arenberg DA, Carskadon SL, Zhao L, White ES McClelland MR, American Thoracic Society, San Diego, CA, 5/1/2007
• Diversity and plasticity of the angiogenic switch in lung cancer.
  McClelland MR, Carskadon SL, Zhao L, White ES, Arenberg DA, American Thoracic Society, San Diego, CA, 5/1/2006
• Tumor derived fibroblasts are pro-angiogenic.
  McClelland M, Gray A, Carskadon S, Zhao L, and Arenberg DA, American Thoracic Society, San Diego, CA, 5/1/2005
• Oxidase-Dependent Expression of Angiogenic Activity by Non-small Cell Lung Cancer Cells
  Arenberg DA, Carskadon SL, Thannickal VJ and Keshamouni, V, American Thoracic Society, Orlando, FL, 5/1/2004
• Tumor Derived Fibroblasts in Lung Cancer; A Distinct Sub-population of Lung Fibroblasts.
  Arenberg DA, Gray A, Carskadon SL, White ES, AACR, Orlando, FL, 3/1/2004
• GP91phox-dependent Expression of Angiogenic CXC Chemokines in Human Non-Small Cell Lung Cancer.
  Arenberg DA, Carskadon SL, Thannickal VJ, The Thomas Petty Aspen Lung Conference, 6/1/2003
• H2O2-dependent Expression of Angiogenic CXC Chemokines by Human Non-Small Cell Lung Cancer Cells.
  Arenberg DA, Carskadon SL, Thannickal VJ, AACR, Toronto, Ontario, Canada, 4/1/2003
• Evidence for Selective PPAR Modulation in Lung Cancer.
  Keshamouni V, Joel B, Reddy R, Arenberg DA, Standiford T, Keystone Symposia on PPAR, 2/1/2003
• Basement Membrane Invasion by Lung Fibroblasts from IPF: Role of paxillin and pp125FAK.
  White ES, Carskadon SL, Dickey EG, Arenberg DA, ATS, Seattle, WA, 1/1/2003
• Peroxisome Proliferator-Activated Receptor (PPAR) Agonists Impede Growth in Non-Small Cell Lung Cancer By Inhibiting Cell Proliferation and Angiogenesis.
  Keshamouni V, Reddy R, Joel B, Arenberg DA, Newstead M, Standiford T, ATS, Seattle, WA, 1/1/2003
• Redox regulation of apoptotic resistance in lung cancer cells.
  Keshamouni V, Arenberg DA, Joel B, Reddy R, Standiford T, Thannickal VJ, ATS, Seattle, WA, 1/1/2003
• Macrophage Migration Inhibitory Factor (MIF) Promotes Chemokine Mediated Angiogenesis In Lung Cancer.
  Arenberg DA, White ES, Carskaddon S, ATS, Seattle, WA, 1/1/2003
• Invasive Behavior of Lung Fibroblasts from Fibrotic Diseases: Role of the alpha4beta1 and alpha5beta1 Integrins.
  White ES, Carskadon SL, Dickey EG, Arenberg DA, ATS, Seattle, WA, 1/1/2003
• Expression of macrophage migration inhibitory factor (MIF) in human non-small cell lung cancer (NSCLC).
  Arenberg DA, Carskaddon S, White ES, Midwest Section-AFMR, Chicago, IL, 9/1/2002
• Fibrotic-lung fibroblast invasion of basement membranes is modulated by PTEN.
  White ES, Carskadon SL, Livant DL, Markwart S, Toews GB, Arenberg DA, Am J Respir Crit Care Med, 1/1/2002
• Macrophage infiltration of murine lung cancer tumors: role in angiogenesis.
  Arenberg DA, White E and Carskaddon S, Am J Respir Crit Care Med, 1/1/2002
• Macrophage migration inhibitory factor (MIF) in pulmonary fibrosis.
  Lama VN, Arenberg D, Flaherty K, Moore B, Kazerooni E, Standiford T, Toews G, Martinez FJ, Am J Respir Crit Care Med, 1/1/2002
• Induction of chemokine dependent angiogenic activity by macrophage migration inhibitory factor (MIF).
  Arenberg DA, Wys NL, and White E, Keystone Symposium on Chemokines and Chemokine Receptors, Taos, NM, 2/1/2001
• Inhibition of lung cancer derived chemokine expression by atorvastatin.
  Arenberg DA and Wys N, FASEB J, 1/1/2001
• Migration inhibitory factor (MIF) expression in lung cancer promotes angiogenesis.
  Arenberg DA, Wys N, White ES, Am J Respir Crit Care Med, 1/1/2001
• White ES, Wys NL, and Arenberg DA, Am J Respir Crit Care Med, 1/1/2001
• Fibronectin is a Key Mediator of Macrophage-Derived Angiogenic Activity.
  White ES, Wys N, Strom SR, Arenberg D, Cytokines and Cancer: Regulation, Angiogenesis, and Clinical Applications. American Association for Cancer Research, 9/20/2000
• In vitro interaction between non-small cell lung cancer cells and monocytes.
  White ES, Strom SR, Arenberg DA, Am J Respir Crit Care Med, 1/1/2000
• IL-12 attenuates bleomycin-induced pulmonary fibrosis by inducing expression of IFN-gamma.
  Keane MP, Belperio JA, Arenberg DA, Burdick MD, Strieter RM, Am J Respir Crit Care Med, 1/1/2000
• Join now to see all

Lectures

• Cellvizio Pulmonary Roundtable Discussion. Invited Speaker 
  12/1/2014
• Emerging Science and Therapies in Lung Cancers 
  New York, NY - 11/1/2014
• Key Components of a Lung Cancer Screening Program. Invited Speaker 
  Gratiot Hospital, Midland, MI - 11/1/2014
• Lung Cancer Evaluation and Treatment: an Evolving Paradigm. Chair, Invited Speaker 
  Austin, TX - 10/1/2014
• Bais, Bonsuses and Benfits: Understanding of Data from Lung Cancer Screening Trails. Invited Speaker 
  Troy, MI - 10/1/2014
• PET Scans: The Swiss Army Knife of Thoracic Oncology. Chair and Invited Speaker 
  Austin, TX - 10/1/2014
• What is Multifocal Lung Cancer, and How Do We Manage IT? Panel Discussion 
  Austin, TX - 10/1/2014
• Pulmonary Nodule Workup 
  University of Michigan , Ann Arbor, MI - 9/10/2014
• Technical and Practical Aspects fo Bronchscopy 
  University of Michigan , Ann Arbor, MI - 9/6/2014
• Lung Cancer Screening 
  University of Michigan , Ann Arbor, MI - 8/8/2014
• Cell and Molecular Biology Lecture 
  Chicago, IL - 8/1/2014
• Neoplasms Lecture 
  Chicago, IL - 8/1/2014
• Implementation of Lung Cancer Screening. Invited Speaker and Participant 
  San Deigo, CA - 5/1/2014
• Diagnosis and Management of Lung Cancer. Chair and Speaker 
  San Antonio, TX - 3/1/2014
• Diagnostic Approach to the Patient With Suspected Lung Cancer. Invited Speaker 
  Chicago, IL - 10/1/2013
• ACCP Lung Cancer III Guidelines: Treatment of Early Lung Cancer (NSCLC). Speaker 
  Chicago, IL - 10/1/2013
• Present and Future Targeted Lung Cancer Therapy: Beginning the End of Nihilism. Chair and Invited Speaker 
  Chicago, IL - 10/1/2013
• Lung Cancer Screening: Practical Lessons From Early Experiences. Invited Speaker 
  Chicago, IL - 10/1/2013
• Synergistic Perspectives in NSCLC Management. Invited Speaker 
  Chicago, IL - 9/1/2013
• Pulmonary Board Review. Invited Speaker 
  Chicago, IL - 8/1/2013
• Lung Cancer 
  University of Michigan , Ann Arbor, MI - 7/19/2013
• Diagnosis and Staging of Lung Cancer 
  University of Michigan , Ann Arbor, MI - 7/9/2013
• Internal Medicine Update, Speaker 
  Mackinac Island, MI - 7/1/2013
• Lung cancer Screening: Moving Forward. Symposium Chair and Speaker 
  5/1/2013
• Lung cancer screening: Evidence Based Review 
  5/1/2013
• Join now to see all